An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Several experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Elimination
According to the social media company, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.
After moments of entering one group, a seller posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Inside these groups, posts show black plastic parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for the messaging service stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject users to possibly significant health risks”.
